For the treatment of infections caused by MDR Gram-negative bacilli, carbapenems are recommended for severe infections caused by third-generation cephalosporin-resistant Enterobacterales, with alternatives, such as beta-lactam/beta-lactamase inhibitors (BLBLIs), SXT and FQs for low-risk cases [19]. The gene discussed is LACTB; the disease is infection.